Sofosbuvir and risk of estimated glomerular filtration rate decline or end‐stage renal disease in patients with renal impairment

Author:

Sulkowski Mark1ORCID,Telep Laura E.2,Colombo Massimo3,Durand Francois4,Reddy K. Rajender5,Lawitz Eric6,Bourlière Marc78,Cheinquer Nelson2,Scherbakovsky Stacey2,Ni Liyun2,Force Lindsey2,Ramroth Heribert2,Gaggar Anuj2,Chokkalingam Anand P.2ORCID,Sise Meghan E.9ORCID

Affiliation:

1. Johns Hopkins University School of Medicine Baltimore Maryland USA

2. Gilead Sciences, Inc. Foster City California USA

3. M Colombo Liver Center San Raffaele Hospital Milan Italy

4. Hôpital Beaujon University Paris Diderot Clichy France

5. Department of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

6. Texas Liver Institute University of Texas Health Science Center San Antonio Texas USA

7. Hépato‐Gastro‐Entérologie Hôpital Saint Joseph Marseille France

8. INSERM 1252, IRD, Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale Aix‐Marseille University Marseille France

9. Massachusetts General Hospital Boston Massachusetts USA

Funder

Gilead Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3